Illustration: Axios Visuals
Eli Lilly has agreed to buy sleep disorder biotech Centessa Pharmaceuticals in a deal worth up to $7.8 billion, the companies announced Tuesday.
Why it matters: Pharma M&A is moving at a fast clip, with several other large transactions inked this month.
